CPIG
CGTX icon

Chicago Partners Investment Group’s Cognition Therapeutics CGTX Stock Holding History

Chicago Partners Investment Group’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5K Hold
10,909
– – ﹤0.01% 1566
2026
Q1 		$14.1K Sell
10,909
-11
-0.1% -$13 ﹤0.01% 1466
2025
Q4 		$15.6K Hold
10,920
– – ﹤0.01% 1292
2025
Q3 		$17.4K Buy
10,920
+120
+1% +$164 ﹤0.01% 1211
2025
Q2 		$8.69K Hold
10,800
– – ﹤0.01% 1094
2025
Q1 		$3.83K Buy
+10,800
New +$6.35K ﹤0.01% 933

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.47B AUM 18.73% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Chicago Partners Investment Group's CGTX Position: Q2 2026 in Review

Chicago Partners Investment Group held its Cognition Therapeutics (CGTX) position steady in Q2 2026 at 10,909 shares worth $10.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1566.

Chicago Partners Investment Group first reported a position in CGTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $17.4K in Q3 2025. 66 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

  • Chicago Partners Investment Group held 10,909 shares of Cognition Therapeutics worth $10.5K as of Q2 2026.
  • Chicago Partners Investment Group left its Cognition Therapeutics share count unchanged in Q2 2026.
  • Cognition Therapeutics made up ﹤0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #1566 holding.
  • Chicago Partners Investment Group first reported a position in Cognition Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Chicago Partners Investment Group's Cognition Therapeutics position peaked at $17.4K in Q3 2025.
  • 66 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.